&w=3840&q=100)
Buyer found for TikTok, identities to be revealed soon, says Donald Trump
US President Donald Trump said in a Fox News interview broadcast on Sunday that he had found a buyer for the TikTok short-video app, which he described as a group of "very wealthy people" whose identities he will reveal in about two weeks.
Trump made the remarks in an interview on Fox News ' "Sunday Morning Futures with Maria Bartiromo" program. He said the deal he is developing would probably need China's approval to move forward and he predicted Chinese President Xi Jinping would likely approve it.
The US president earlier this month had extended to September 17 a deadline for China-based ByteDance to divest the U.S. assets of TikTok despite a law that mandated a sale or shutdown without significant progress.
A deal had been in the works this spring that would have spun off TikTok's U.S. operations into a new U.S.-based firm, majority-owned and operated by U.S. investors, but it was put on hold after China indicated it would not approve it following Trump's announcements of steep tariffs on Chinese goods.
"We have a buyer for TikTok, by the way," Trump said. "I think I'll need probably China's approval. I think President Xi will probably do it."
A 2024 U.S. law required TikTok to stop operating by January 19 unless ByteDance had completed divesting the app's U.S. assets or demonstrated significant progress toward a sale.
Trump, who credits the app with boosting his support among young voters in last November's presidential election, has extended the deadline three times.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
25 minutes ago
- Business Standard
Trump's tariffs and tax policies test assumptions on US dollar, markets
By Alice Gledhill, Malavika Kaur Makol and Sagarika Jaisinghani Six months since Wall Street laid out its predictions for 2025, world conflicts and President Donald Trump's turbulent policy making have shattered assumptions about the strength and preeminence of US assets and the economy — leaving market favorites in tatters and conjuring unexpected winners. As foreseen: swings in sovereign bond markets have been sharp, the Japanese yen rallied, and a comeback for emerging markets is finally materialising. At the same time, few envisaged the dollar — the emblem of US exceptionalism — would suffer losses this deep, or predicted the S&P 500's giddying plunge followed by breakneck rebound. Europe's stock market, meanwhile, has morphed from backwater into investor must-have. Here's a look into a group of assets and how they performed so far this year: US dollar Trump's low-tax, high-tariff policies were expected to stoke inflation and reduce the chances of interest-rate cuts from the Federal Reserve — factors seen propelling the dollar's supremacy well into 2025. Instead, a Bloomberg gauge of the currency posted its worst start to a year since at least 2005, and its hegemony is being debated ever more fiercely. The ' Liberation Day' tariffs at the start of April were so sweeping and punitive that they fueled fears of a US recession and fanned speculation Trump was seeking to buoy domestic manufacturing by engineering a weaker dollar. That's a dangerous game: the US depends on foreign investors to buy its mountainous debt pile, and a weaker greenback erodes returns on those bonds. Societe Generale SA, Morgan Stanley and JPMorgan Chase & Co. hadn't expected a turn in the dollar's fortunes in the first half and only predicted gradual slippage later in the year. Now, a JPMorgan team led by Meera Chandan says the greenback's faltering link to rates and equities could be a sign of structural weaknesses. They predict a gauge of the US currency's strength will drop another 2 per cent by year-end. US stocks Investors entered the year with a record high allocation to US stocks, emboldened by a robust economy and bets around artificial intelligence. That optimism was all but abandoned within months, first as Chinese startup DeepSeek challenged the US's dominance in the AI race, and later on fears that Trump's tariffs would tip the economy into a recession. Nearly $7 trillion of market capitalization was wiped from the technology-heavy Nasdaq 100 Index between a February peak and an April low. A Bank of America Corp. fund manager survey showed the biggest-ever drop in exposure to US stocks in March. By early April, US equity bulls were in short supply. But Trump's decision later that month to pause some of the highest tariffs in a century proved pivotal. The S&P 500 hit a record high as data show the economy chugging along and with technology heavyweights in vogue again. After months of ructions and tempered forecasts, Wall Street strategists are taking an optimistic tone on US stocks for the second half. 'I am as bullish on US stocks as ever,' said Marija Veitmane, a senior multi-asset strategist at State Street Global Markets. 'They still offer the best earnings story with the fastest growth and most predictability. Institutional investors restarted buying in mid-April and have not looked back since.' Asian currencies With the Bank of Japan prepared to raise interest rates at a time when peers were cutting, traders started 2025 confident they'd see a rally in the yen. JPMorgan Asset Management and Brandywine Global Investment Management were among those proved right by the currency's almost 9 per cent surge against the dollar to around 145 this year. The yen got a further boost in April from surging demand for haven assets amid the confusion around Trump's tariffs. Jupiter Asset Management's Mark Nash, who positioned for the rally in January, forecasts the currency will climb to 120 per dollar by year-end, an advance of around 17 per cent from current levels. In China, meanwhile, US trade tariffs were expected to hurt the yuan, but so far the dollar's own sharp selloff has upended the prediction. In December, Nomura called for the yuan to weaken to 7.6 per dollar in offshore trading by May, and JPMorgan saw a rate of 7.5 in the second quarter. Instead, the yuan has surged 1.8 per cent this year, hitting 7.1565 per dollar on Thursday — the highest level in seven months — as the People's Bank of China strengthened the daily reference rate. Still, strategists say the yuan will eventually have to fall, given strains in the Chinese economy that may require monetary and fiscal easing in the second half of the year to lift growth. 'China will want to utilize the yuan as a release valve, as well as to maintain competitiveness given the ongoing pressure on the economy and the fact that exports remain the main engine of growth," Barclays Bank Plc strategists Mitul Kotecha and Lemon Zhang wrote in a June 24 note. They see the yuan weakening to 7.20 per dollar by the end of the year, and to 7.25 by March 2026. Global bonds Amid the turbulence, many investors were grateful for one trade that 'saved their bacon,' according to Jared Noering, global head of fixed income trading at NatWest Markets. Short-dated government bonds were expected to perform well, boosted by central bank interest-rate cuts as inflation eased further. In contrast, long-dated bonds were predicted to come under pressure as governments took on increasing levels of debt to plug deepening fiscal deficits and ramped up public spending. Wagers structured around this divergence have largely played out around the globe, including in the US where markets remain on edge over the administration's tax and spending plans. Measures of so-called term premium in longer-dated US Treasuries have soared in an indication buyers are demanding higher compensation for rampant borrowing. Pimco and Allspring Global Investments correctly predicted the divergence in short- and longer-term yields in global bond markets. BlackRock Investment Institute was also correct to underweight long-term Treasuries. European stocks It was hard to find fans of European equities at the start of the year, let alone investors betting they would outshine their US peers. Six months on, fears about a sluggish economy and the threat of tariffs have been offset by Germany's plans to unleash hundreds of billions of euros in defense spending after Trump demanded Europe foots its own military bill instead of relying on the martial heft of the US. As of June 27, the benchmark Stoxx 600 index had trounced the S&P 500 by 16 percentage points in dollar terms, the best relative performance since 2006. The euro has surged to $1.17, bucking widespread forecasts for parity with the dollar in early 2025. Beata Manthey, Citigroup Inc.'s head of European and global equity strategy, was among the rare voices to back European stocks late last year. Targets at JPMorgan and Goldman Sachs proved too cautious. Goldman's chief global equity strategist, Peter Oppenheimer, says much has changed: 'Very aggressive tariffs are not likely to be fully implemented.' Emerging-market comeback Every year since 2017, emerging-market equities lagged US stocks. In 2025, a procession of money managers — with Morgan Stanley among the most vocal — were convinced it was going to be different. And so far the jinx appears to have been broken. A boom in artificial intelligence companies from Taiwan, South Korea and China has helped the equity index. But the overall investment case for emerging markets is underpinned by broad currency strength against the greenback and the perception that the period of US exceptionalism is waning. Emerging markets have added $1.8 trillion to shareholder wealth in 2025, reaching record market capitalization of $29 trillion. Bernd Berg, a strategist at InTouch Capital Markets, expects those inflows to continue thanks to benign inflation and decent growth rates. 'The geopolitical tensions have not derailed this rally,' Berg said. In individual developing markets, Turkey's lira took a hit in March — tumbling to a record low in the space of half an hour — after President President Recep Tayyip Erdogan detained his main political rival. That spooked investors who'd borrowed funds in countries where interest rates were low and plowed the cash into high-yielding lira-denominated assets. They feared the political shock could eventually herald changes in the country's market-friendly economic policy and high central-bank interest rates. While the broader fears haven't materialized, investors are wary, with Pimco among those trimming exposure to Turkish bonds. Meanwhile, the failure of Trump's push for peace between Russia and Ukraine has seen the price of Ukrainian bonds slump. Once a favorite investor bet on a ceasefire, Ukrainian warrants, which have interest payments linked to economic growth, have tumbled since the government defaulted on a payment.
&w=3840&q=100)
Business Standard
25 minutes ago
- Business Standard
Torrent Pharma share pops 4% on ₹25,689-cr JB Chem deal; analysts cautious
Torrent Pharmaceuticals has signed a definitive agreement to acquire a controlling stake in JB Chemicals and Pharmaceuticals (JBCP) at a fully diluted equity valuation of ₹25,689 crore. Tanmay Tiwary New Delhi Torrent Pharma share price today: Pharmaceutical company Torrent Pharmaceuticals shares were in focus on Monday, June 30, after the company announced a massive ₹25,689-crore deal to acquire JB Chemicals & Pharmaceuticals (JBCP). The Torrent Pharmaceuticals share surged as much as 3.89 per cent intraday to ₹3,474.60 apiece before paring gains. At last count, shares were trading 0.72 per cent higher at ₹3,368.35, even as the BSE Sensex remained flat around 84,003.81. The deal Torrent Pharmaceuticals has signed a definitive agreement to acquire a controlling stake in JB Chemicals and Pharmaceuticals (JBCP) at a fully diluted equity valuation of ₹25,689 crore. The transaction, structured in two phases, begins with Torrent Pharmaceuticals acquiring 46.39 per cent stake via a share purchase agreement (SPA) at ₹1,600 per share, amounting to ₹11,917 crore. This will be followed by an open offer to buy up to 26 per cent from public shareholders at ₹1,639 per share. Additionally, Torrent Pharmaceuticals said that it aims to acquire 2.8 per cent of JB Chemicals and Pharmaceuticals' equity from certain employees at the same price offered to KKR. As part of the transaction, Torrent Pharmaceuticals and JB Chemicals and Pharmaceuticals will merge—JB Chemicals shareholders will receive 51 Torrent Pharmaceuticals' shares for every 100 JB Chemicals and Pharmaceuticals shares held. The deal is now pending shareholder and Competition COmmission of India (CCI) approvals and is expected to close in six months. Brokerages' view Brokerages broadly see the deal as strategically major, though the near-term impact remains mixed. According to domestic brokerage firm Motilal Oswal, the acquisition provides Torrent Pharmaceuticals with a diversified branded portfolio that includes several potential mega brands, a pan-India reach supported by a 2,800-strong medical representative field force, robust manufacturing infrastructure for multiple dosage forms, and access to a growing Contract Development and Manufacturing Organisation (CDMO) business driven by lozenges. The brokerage believes this acquisition is value accretive over the medium to long-term. Excluding the impact of JB Chemicals and Pharmaceuticals, Torrent Pharmaceuticals is expected to post a 12 per cent revenue, 14 per cent Ebitda, and 23 per cent PAT CAGR over FY25–27. The brokerage values the stock at 38x 12-month forward earnings, arriving at a target price of ₹3,430. However, it maintained a 'Neutral' rating, citing limited upside from current levels despite the deal's long-term merits. Those at Japan-based foreign brokerage firm Nomura noted that the move aligns with Torrent Pharmaceuticals' history of inorganic growth, particularly in India. The acquisition offers near-term cost synergies and potential long-term revenue synergies, especially as both firms have a dominant presence in the Cardiac and Gastro segments. However, it flagged concerns around execution risks given the unprecedented size of this deal for Torrent. Unlike past acquisitions, valuation premiums are higher, and there's limited headroom for operational improvement as JBCP is already a well-run business with strong market share in key products. In the near-term, the acquisition could be earnings dilutive, especially when factoring in higher interest and amortisation costs. Excluding amortisation, the deal may be marginally EPS accretive—if merged using Torrent stock. Thus, Nomura maintained a 'Neutral' rating on Torrent Pharmaceuticals with a target price of ₹3,580, based on 25x FY27 Ebitda of ₹4,850 crore. The stock currently trades at 26.1x one-year forward Ebitda. While analysts are mixed on the immediate financial impact, the Street appears optimistic about Torrent Pharmaceuticals' long-term strategic play in scaling up its domestic and international presence through this acquisition.
&w=3840&q=100)
Business Standard
26 minutes ago
- Business Standard
Russia tries again to boost LNG exports stalled by US sanctions last year
Russia has the pieces in place to meaningfully boost LNG exports as it expands its shadow fleet Bloomberg Russia is taking another crack at expanding exports of liquefied natural gas after US sanctions stalled efforts last year. An LNG vessel has docked and then left the Arctic LNG 2 export facility for the first time since October, according to ship-tracking data compiled by Bloomberg and satellite images. The facility was supposed to be a cornerstone of Moscow's goal to triple LNG exports by 2030, but has been idle for months after struggling to find buyers willing to break Western restrictions. Russia has the pieces in place to meaningfully boost LNG exports as it expands its shadow fleet. Since the 2022 invasion of Ukraine, Russian gas pipeline exports to Europe have dwindled, and shipping more fuel via seaborne LNG tankers provides an attractive revenue stream to fill Moscow's coffers. Shadow fleet At least 13 ships, including those that can navigate icy waters, have been marshaled to potentially service Arctic LNG 2, with some changing management companies several times to help obfuscate the actual owners. According to ship-tracking data compiled by Bloomberg they include: Four ice-class vessels that can navigate the frozen waters around Arctic LNG 2. Three are currently idled in the Barents Sea, while another is the tanker currently docked at Arctic LNG 2 Three more traditional LNG vessels are in the Barents sea Two vessels are under repair in China, with another that appears to be on the way One vessel near a floating storage in Russia's Far East Two vessels are idled in the the Gulf of Finland. They had served another Russian facility called Portovaya, which was sanctioned by the US in January 'Russia does have more vessels at its disposal compared to the summer/fall of 2024,' Malte Humpert, founder of the Arctic Institute, a Washington-based think-tank, said in an email. 'If it can find buyers, this small fleet should be sufficient to lift cargoes.' Eight shipments were exported from Arctic LNG 2 between August and October 2024, but never docked on foreign shores. Instead, the gas was offloaded into two Russian storage units in the Barents Sea and its Far East region. Large-scale production halted in October after ice built up around the facility and made transport by traditional vessels challenging. Russia's first domestically built ice-class LNG tanker may come online in the second half of this year if it passes remaining sea trials, Interfax reported Wednesday, citing Sovcomflot Chief Executive Officer Igor Tonkovidov. Willing buyers? Now, the market will be closely monitoring whether Arctic LNG 2 can find willing buyers. Exporting more would be a boon for consumers, as it would put pressure on global gas prices. The Biden administration was diligent in sanctioning ships and companies connected with exporting fuel from Arctic LNG 2 last year. It isn't clear if the Trump administration will be as strict, or if the government will slap restrictions on ports that accept the fuel. The threat of retaliation from the US kept buyers at bay last year. Officials related to the Arctic LNG 2 joint venture have never stopped trying to sell the fuel, traveling to potential buyers in India and China over the last year, according to traders with knowledge of the matter. However, it isn't clear if they have been able to secure any sales. 'The biggest obstacle remains finding a buyer and shipping capacity,' Jan-Eric Fahnrich, a senior analyst at Rystad Energy, said by email. 'They will then circle around looking for buyers in Asia and Novatek will offer a discount.' Majority shareholder Novatek PJSC and the operating venture Arctic LNG 2 did not respond to emails seeking comment. Iris, the tanker that recently left Arctic LNG 2, is now heading toward the northern port of Murmansk, according to ship-tracking data. The vessel could be traveling there to offload fuel into a nearby floating storage unit or another vessel in a ship-to-ship transfer. It's not immediately clear if any LNG was loaded on the vessel. The tanker's draft level — which the crew inputs manually — didn't change after leaving the plant, the data shows, signaling it may not have loaded LNG cargo. The Iris is expected to reach Murmansk on July 1, according to the data. 'The fact that more than one million cubic meters of LNG loaded last year remains unsold, and in floating storage, does not bode well for renewed attempts to market additional volumes this summer,' said the Arctic Institute's Humpert. 'China would appear to be the most likely candidate, but with consistently declining Chinese demand for the past eight months this won't be an easy task.' Iris is also a so-called Arc4 vessel, with a reinforced hull that allows it to navigate icy waters. That would allow the ship to take the shorter Arctic route to Asia when conditions allow in the summer. Loading vessels at Arctic LNG 2 could also be necessary to ease brimming gas tanks. Satellite images taken June 25 indicate that two production trains at the facility are flaring, which indicates they could be operating or cooling down equipment. Without steady exports, the plant's storage will quickly fill up, and lack of space was one of the reasons why Arctic LNG 2 stopped large-scale production in October. Meanwhile, traders will wait to see if US or European officials further tighten restrictions on the facility as exports resume. 'Now is the time for increased pressure' on Russia's energy revenues, said Geoffrey Pyatt, distinguished fellow at the Atlantic Council Global Energy Center and a former US assistant secretary of state who helped craft Arctic LNG 2 sanctions under the Biden administration. 'European leaders have expressed new determination to end all imports of Russian gas, making it even more important that the United States maintains our pressure on Novatek.'
